Abbott reports second-quarter 2017 results
Abbott reported second-quarter 2017 worldwide sales of $6.6 billion, an increase of 24.4 percent on a reported basis and 2.9 percent on a comparable operational basis over the prior year period. Diluted GAAP EPS from continuing operations was $0.15 in the second quarter. July 20, 2017